XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis
The following table presents information about the fair value measurement of the Company’s financial instruments (in thousands):
  
As of December 31,
Financial Instruments Recorded at Fair Value on a Recurring Basis:Fair Value Measurement Level20232022
Assets:
Derivative assets—foreign currency contracts (1)
2$76 $— 
Derivative assets—interest rate swap contract (2)
216,248 23,410 
Total assets$16,324 $23,410 
Liabilities:
Derivative liabilities—foreign currency contracts (3)
2$— $1,001 
Contingent consideration—earn out (4)
315,000 22,747 
Total liabilities$15,000 $23,748 
(1)Included in prepaid expenses and other current assets in the accompanying consolidated balance sheets.
(2)Included in prepaid expenses and other current assets and other non-current assets in the accompanying consolidated balance sheets.
(3)Included in other current liabilities in the accompanying consolidated balance sheets.
(4)Included in current and non-current contingent consideration in the accompanying consolidated balance sheets.
Schedule of Fair Value Contingent Consideration
The following table presents the fair value of contingent consideration (in thousands):
Year-ended December 31,
202320222021
Contingent consideration, beginning of period
$22,747 $25,300 $— 
Acquisition date fair value of contingent consideration
— — 21,500 
Payments of contingent consideration(12,445)(12,555)— 
Change in fair value of contingent consideration
4,698 10,002 3,800 
Contingent consideration, end of period
$15,000 $22,747 $25,300 
Schedule Of Fair Value Of Contingent Consideration
The following table reconciles the changes in fair value of contingent consideration and payments of contingent consideration to the accompanying consolidated statement of cash flows and consolidated statements of operations and comprehensive loss (in thousands):
Year-ended December 31,
202320222021
Total payment of contingent consideration
$12,445 $12,555 $— 
Less: amounts paid in excess of the acquisition date fair value of the contingent consideration (1)
(220)(3,280)— 
Acquisition date fair value of contingent consideration (2)
$12,225 $9,275 $— 
Change in fair value of contingent consideration (3)
$4,698 $10,002 $3,800 
Less: amounts paid in excess of the acquisition date fair value of the contingent consideration (1)
(220)(3,280)— 
Net change in fair value of contingent consideration (4)
$4,478 $6,722 $3,800 
(1)Included in the change in fair value of contingent consideration as an operating activity in the accompanying consolidated statement of cash flows.
(2)Agrees to the payments of acquisition related contingent consideration as a financing activity within the accompanying consolidated statement of cash flows.
(3)Agrees to the change in fair value of contingent consideration in the accompanying consolidated statement of operations and comprehensive loss.
(4)Agrees to the change in fair value of contingent consideration as an operating activity in the accompanying consolidated statement of cash flows.
Schedule of Financial Instruments Recorded at Carrying Amount
The following financial instruments are recorded at their carrying amount (in thousands):
 
As of December 31, 2023
As of December 31, 2022
Financial Instruments Recorded at Carrying Amount:Carrying
Amount
Estimated
Fair Value
Carrying
Amount
Estimated
Fair Value
Liabilities:
Debt—Credit Facilities (1)
$403,825 $357,498 $476,070 $393,236 
Total liabilities$403,825 $357,498 $476,070 $393,236 
(1)Included in the current portion of notes payable and notes payable, net of current portion in the accompanying consolidated balance sheets. Due to the unobservable nature of the inputs these financial instruments are considered to be Level 3 instruments in the fair value hierarchy